Sean M. Healey & AMG Center for ALS Announces First Participant Enrolled in Regimen I of the HEALEY ALS Platform Trial Evaluating NUZ-001 by Neurizon Therapeutics. Sean M. Healey & AMG Center for ALS Announces First Participant Enrolled in Regimen I
Emerging research from the Clotilde Lagier-Tourenne Lab, in collaboration with Franck Martin's Lab at the University of Strasbourg, is shedding new light on how genetic mutations in the C9ORF72 gene cause ALS and frontotemporal dementia (FTD).
The PACT Program provides guidance to parents and grandparents with ALS on how to talk to children about the illness and support their healthy coping with it. Learn more.
The Sean M. Healey & AMG Center for ALS at Mass General Brigham awarded the seventh annual Sean M. Healey International Prize for Innovation in ALS to the team of researchers who discovered that nucleotide-repeat expansions can cause ALS, revealing disease mechanisms and therapeutic targets.
The Sean M. Healey & AMG Center at Massachusetts General Brigham awards the fifth annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing to Dr. Frank Bradke. Learn more.
The Sean M. Healey & AMG Center for ALS at Mass General Brigham has selected Tiziana Life Sciences as one of the companies to enter the Healey ALS MyMatch Program. Learn more.
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital has contracted with Inflammasome Therapeutics to design a new Healey ALS MyMatch trial. Learn more.
Sean M. Healey & AMG Center for ALS Announces Completion of Enrollment for First Healey ALS MyMatch Trial. Sean M. Healey & AMG Center for ALS Announces Completion of Enrollment for First Healey ALS MyMatch Trial. The Sean M. Healey & AMG Center for
The Sean M. Healey & AMG Center for ALS is pleased to announce that Cedric Böger, a PhD student at the German Center for Neurodegenerative Diseases (DZNE), has been awarded the 3rd annual Drs. Ayeez and Shelena Lalji & Family Student Scholar for Repair and Regenerative Mechanisms in ALS.
The Sean M. Healey & AMG Center for ALS is pleased to announce that the ALS Residence Initiative (ALSRI) was awarded the 2025 Gupta Family Endowed Prize for Innovation in ALS Care. Merit Cudkowicz, MD, MSC, Director of the Healey & AMG Center for ALS, presented the prize to Steve Saling, CEO of ALSRI, and Barry Berman, CEO of Chelsea Jewish Lifecare.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.
